Skip to main content
OpenTrials
Completed

NCT Number: NCT04492930

Effect of 14:10 Time-Restricted Eating on Body Weight and Metabolic Markers

The purpose of this study is to investigate the effect of engaging in time restricted eating schedule on body weight, blood glucose, and ketones (breath acetone) in individuals with obesity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jenny Craig

Carlsbad, California, 92008, United States

About this study

There are significant metabolic and weight reduction benefits associated with time restricted feeding/eating. Time restricted eating splits the day into a period of regeneration (non-eating or natural fasting) and a period of nourishing. Providing the body a period of regeneration allows the body to go into ketosis, or the elevation in circulating ketone bodies, a byproduct of fat metabolism. Breath acetone concentration is a good predictor of ketosis and loss of body fat. In healthy individuals, low concentrations of breath acetone are 1 to 2 ppm. Engaging in weight loss via nutritional ketosis (engaging in high-fat, low-carbohydrate diets, caloric restriction diets, or fasting) increases fat utilization, resulting in increased formation of ketone bodies and breath acetone concentrations ranging from 4 to 30 ppm. In individuals with obesity, nutritional ketosis facilitates weight loss and improves insulin sensitivity, lipid profile, and reduces inflammatory markers.

This study will investigate the effect of participating in two different time restricted eating schedules for 8 weeks on body weight, blood glucose, and ketones.

After being informed about the study and potential risks, all eligible participants giving written informed consent will be randomized to a different time restricted eating schedule (ie, one group fasts for a longer period of time). In both of these groups, fasting will begin each evening and end the following morning.

This is a remote study. All procedures will be conducted at home.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female individuals between the age of 18 to 65 years (inclusive) at the time of signing the informed consent
  • Enrollment in the Jenny Craig® Rapid Results™ program
  • Access to a tablet or smartphone with a camera and internet access
  • Body mass index (BMI) at least 30 kg/m2
  • Ability to use a glucometer and Levl device (measures breath acetone)
  • Female participants of childbearing potential will agree to avoid pregnancy during the study. Medically acceptable methods of contraception include oral contraceptive medication, an intrauterine device (IUD), an implantable contraceptive (such as Implanon), an injectable contraceptive (such as Depo-Provera), a barrier method (such as condom or diaphragm with spermicide), abstinence, or having exclusive sexual relations with a vasectomized or same sex partner.
  • Capable of giving signed informed consent.

Exclusion criteria

  • Current use of the medications indicated for weight management or treatment of diabetes or for treatment of psychosis
  • Serious allergy to corn, corn products, or gluten (due to the number of Jenny's Cuisine® items that contain these food ingredients) that results in throat swelling, rash, hives, or anaphylactic shock
  • Serious allergy to milk, soy, wheat, peanuts, or tree nuts that results in throat swelling, rash, hives, or anaphylactic shock
  • Celiac disease
  • Currently being treated with hemodialysis
  • Currently being treated for anorexia/bulimia
  • Require a special diet (vegan, kosher, or halal)
  • Had a baby within the last 6 weeks
  • Are currently breastfeeding
  • Are pregnant
  • Bariatric surgery within the previous 3 years
  • Individuals belonging to the following vulnerable populations (people with disabilities, people who cannot read, educationally disadvantaged, individuals with a serious or life threatening illness, prisoners, non-English speakers, economically disadvantaged individuals, employees of the study sponsor)

Treatment and study plan

14:10 Regimen

Behavioral

14 hours of fasting, followed by a 10-h diet regimen that includes a fasting snack at 12 hours from the start of the fasting period

12:12 Regimen

Behavioral

12 hours of fasting, followed by a 12-h diet regimen

Primary outcomes

  1. Change in body weight

    Time frame: Week 4

    Change from baseline body weight in the intervention group

  2. Change in ketone levels (breath acetone)

    Time frame: Week 8

    Change from baseline in breath acetone in the intervention group

  3. Change in blood glucose

    Time frame: Week 8

    Change from baseline in blood glucose in the intervention group

Secondary outcomes

  1. Change in body weight

    Time frame: Week 8

    Change from baseline body weight in the intervention group

  2. Difference in weight loss between groups

    Time frame: Weeks 4 and 8

    Difference in the change from baseline in body weight between the intervention and control groups

  3. Time to first meal

    Time frame: Weeks 4 and 8

    Change from baseline in the length of time from consumption of the fasting snack until initiation of the first meal in the intervention group

Other outcomes

  1. Correlation between weight loss and change in ketone levels (breath acetone)

    Time frame: Week 8

    Correlation between the change from baseline in breath acetone and the change from baseline in body weight

Sponsors and collaborators

Lead sponsor

Jenny Craig, Inc.

Industry

Registry information

Official study title

The Effect of 14:10 Hour Time Restricted Eating on Body Weight and Metabolic Markers: An 8-Week Pilot Study in Individuals With Obesity

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 30, 2020
Registry last updated
Nov 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.